All biomarkers articles
-
NewsWho is more likely to get long COVID?
Scientists have identified the key genetic drivers behind long COVID, revealing why some people continue to experience debilitating symptoms long after their initial infection.
-
NewsStudy unravels the fungi-cancer connection
A growing body of evidence indicates that the microbiome within the gut and tumors significantly influences cancer initiation, progression, and treatment response. Current research primarily focuses on bacteria, whilst the role of fungi is only now gaining attention.
-
NewsMucosal virome and host transcriptome interactions reveal viral influence in colorectal polyp development
A new study has provided the first integrated mucosal virome-transcriptome landscape of colorectal polyps, the precursors of colorectal cancer, offering new insights into viral-host interactions at this early disease stage.
-
NewsCuring hepatitis C can rebalance immunity in Indonesians living with HIV
A new study provides the first longitudinal immunological data on HIV/HCV-coinfected individuals in Southeast Asia, underscoring the importance of early hepatitis C treatment to prevent long-term immune and liver complications.
-
NewsGut microbiome connects obesity to cancer, impacting public health
A new review highlights growing scientific evidence that imbalances in gut bacteria can influence metabolism, trigger inflammation, and increase cancer risk. These insights offer new possibilities for disease prevention, early detection, and personalized health care.
-
NewsGut microbiota: implications in pathogenesis and potential therapeutic target in primary biliary cholangitis
A new review synthesizes current evidence on gut microbiota dysbiosis in PBC, elucidates its pathogenic mechanisms, and explores its potential as both a diagnostic biomarker and a novel therapeutic target.
-
NewsAccessible imaging technique can predict cardiac risks in patients with Chagas disease
A simple imaging exam capable of assessing myocardial deformation during contraction has emerged as a promising tool for predicting the risk of cardiac complications in patients with chronic Chagas disease.
-
NewsAll-in-one POM-based nanoreactor with oxidase-like activity for versatile detection and antibacterial action
A research team has developed a novel nanoreactor that enables dual-mode biomarker detection and effective antibacterial treatment.
-
NewsEmerging serum biomarkers for chronic hepatitis B: Focus on serum HBV RNA and HBcrAg
There is a pressing need for non-invasive biomarkers that can accurately reflect the activity of the hepatitis B viral reservoir and predict clinical outcomes. This review synthesizes the evidence for two such promising biomarkers: serum HBV RNA and hepatitis B core-related antigen (HBcrAg).
-
NewsBlood microbial DNA distinguishes liver cancer from metastatic lesions
A simple blood test analyzing microbial DNA could help doctors tell apart primary liver cancer from colorectal cancer that has spread to the liver, according to a new study.
-
NewsResearchers identify a potential biomarker for long COVID
Researchers have identified a potential biomarker for long COVID. The study results detail the detection of SARS-CoV-2 protein fragments within extracellular vesicles (EVs) — tiny, naturally occurring packages that help cells share proteins, metabolites, and other materials.
-
NewsLife on Venus? UK probe could reveal the answer
The answer to whether tiny bacterial lifeforms really do exist in the clouds of Venus could be revealed once-and-for-all by a UK-backed mission. Scientists plan to search and map phosphine, ammonia, and other gases rich in hydrogen that shouldn’t be on the planet.
-
NewsFrom COVID to cancer, new at-home ‘coffee-ring’ test spots disease with startling accuracy
A new, low-cost biosensing technology could make rapid at-home tests up to 100 times more sensitive to viruses like COVID-19. The diagnostic could expand rapid screening to other life-threatening conditions like prostate cancer and sepsis as well.
-
NewsUnderstanding inflammatory bowel disease: An integrative framework of microbiome, metabolome, and immunological biomarkers
A new review underscores the interconnected roles of microbial, metabolic, and immune biomarkers in IBD. While current biomarkers lack universal specificity, integrative approaches and AI-driven analyses offer transformative potential for precision medicine in IBD care.
-
NewsMachine learning method helps bring diagnostic testing out of the lab
A new point-of-care biosensing method, dubbed LOCA-PRAM, improves the accessibility of biomarker detection by eliminating the need for technical experts to perform the image analysis.
-
NewsGut bacteria may hold key to unlocking better cancer treatment
Scientists have discovered a range of microbial ‘biomarkers’ that could help to improve detection and treatment of gastrointestinal diseases (GIDs) such as gastric cancer (GC), colorectal cancer (CRC), and inflammatory bowel disease (IBD).
-
NewsPost-COVID syndrome: new insights into connection between gut health and fatigue
A new study shows that post-COVID syndrome patients have altered inflammatory markers and a disturbed intestinal barrier, which could contribute to the development of post-viral fatigue.
-
NewsScientists find two brain biomarkers in long COVID sufferers may be what’s causing brain fog
A new study that compares inflammation and brain stress responses in long COVID-19 patients with individuals who have fully recovered shows those with cognitive issues have a lower ability to adapt to stress and higher levels of inflammation in their brains.
-
NewsYellow fever vaccination: how strong immune responses are triggered
Researchers have shown how specific immune cells are activated by the vaccine – an important starting point for the development of new vaccines.
-
NewsLong COVID may cause long-term changes in the heart and lungs and may lead to cardiac and pulmonary diseases
Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection, potentially placing them at elevated risk for future cardiac and pulmonary conditions.